Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Pharmacological Research|September 22, 2018
ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progressionYajuan Xiao, Chehade Karam, Jianxun Yi, et al.Xenotransplantation|June 17, 2026
Clinical Trial for Safety of Porcine Islet Xenotransplantation From PERV-C Free DPF Donor Piglets in Patients With Type 1 DiabetesXiaoqian Ma, Zhaohui Mo, Yicong Chen, et al.Kidney Diseases (Basel, Switzerland)|December 13, 2023
Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from ChinaHaitao Zhang, Jingyuan Xie, Chuanming Hao, et al.The Lancet Regional Health. Western Pacific|July 1, 2024
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trialXiang Yan, Jianhua Ma, Yan Liu, et al.Kidney Diseases (Basel, Switzerland)|March 30, 2026
Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup AnalysisPing Li, Yu An, Hongguang Zheng, et al.Frontiers in Endocrinology|May 15, 2025
Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysisPing Li, Hongguang Zheng, Jianhua Ma, et al.Current Medical Research and Opinion|July 14, 2022
Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trialJun Yao, Xiaohui Guo, Li Sun, et al.Diabetologia|March 9, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled studyLinong Ji, Ying Du, Min Xu, et al.Pageof 7